Over 580,000 bottles of a blood pressure medication have been recalled by the U.S. Food and Drug Administration (FDA) due to the potential presence of harmful impurities. The recall affects Prazosin Hydrochloride capsules manufactured by Teva Pharmaceuticals, based in New Jersey. The FDA’s announcement indicates that the medication may contain levels of N-nitroso Prazosin impurity C, a chemical classified as a known carcinogen.
The recall was initiated on October 7, 2023, with the FDA subsequently classifying it as a Class II recall on October 24, 2023. A Class II recall signifies that the product could lead to temporary or medically reversible adverse health consequences, although no adverse effects have been reported as of now.
Details of the Recall
Teva Pharmaceuticals has recalled a total of 580,844 bottles of Prazosin Hydrochloride capsules, which are available in 1 mg, 2 mg, and 5 mg doses. The recall encompasses 55 lots of the medication, with specific lot codes provided in the FDA’s notice for consumer reference. The capsules were distributed nationwide, potentially affecting a wide array of patients.
Consumers are urged to check their medicine cabinets for the recalled product. Teva has reached out to affected customers via letters detailing how to return the recalled medication. Those in possession of the capsules are advised to consult their pharmacies for guidance on how to safely dispose of or return the product.
Consumer Guidance
For individuals who may have questions or concerns regarding the recall, Teva Pharmaceuticals recommends contacting the healthcare provider who prescribed the medication. This step is crucial for patients to receive tailored advice and to ensure their health and safety during this recall period.
In light of this recall, consumers are encouraged to remain vigilant and check their medicine cabinets not only for Prazosin Hydrochloride capsules but also for any other recalled medications. This includes recent recalls involving over 140,000 bottles of a common statin, highlighting the need for ongoing awareness of product safety.
As recalls can impact many individuals, staying informed is essential. The FDA’s website provides updated information on medication recalls, ensuring consumers are aware of any potential health risks associated with their medications.
